符合使用组织型纤溶酶原激活剂（tPA）进行静脉溶栓治疗的伊朗中风患者的评估。 - Suppr

Suppr

超能文献

Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.

作者信息

Ghandehari K, Zahed A Pour, Taheri M, Abbasi M, Gorjestani S, Ahmadi A Moghaddam, Nahayati M A

出版信息

Int J Stroke. 2009 Aug;4(4):236. doi: 10.1111/j.1747-4949.2009.00273.x.

DOI:10.1111/j.1747-4949.2009.00273.x

PMID:19689746

Abstract

摘要

相似文献

Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.符合使用组织型纤溶酶原激活剂（tPA）进行静脉溶栓治疗的伊朗中风患者的评估。

Int J Stroke. 2009 Aug;4(4):236. doi: 10.1111/j.1747-4949.2009.00273.x.

Thrombolysis, community hospitals, and primary stroke center.溶栓治疗、社区医院与初级卒中中心

Acta Neurol Taiwan. 2009 Mar;18(1):1-2.

Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.急性缺血性卒中的静脉溶栓治疗：一家社区医院的经验

Acta Neurol Taiwan. 2009 Mar;18(1):14-20.

Predicted impact of intravenous thrombolysis. Another trial is needed.

BMJ. 2000 Apr 8;320(7240):1007.

Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.估算若能避免延误，适合进行溶栓治疗的中风患者数量。

Cerebrovasc Dis. 2007;23(4):294-8. doi: 10.1159/000098330. Epub 2006 Dec 29.

Utilization of intravenous tissue plasminogen activator for acute ischemic stroke.静脉注射组织型纤溶酶原激活剂在急性缺血性卒中治疗中的应用。

Arch Neurol. 2004 Mar;61(3):346-50. doi: 10.1001/archneur.61.3.346.

Systemic thrombolysis with rt-PA in patients under 40 years of age: a subgroup analysis of the Cologne Stroke Experience.40 岁以下患者接受 rt-PA 系统性溶栓治疗：科隆卒中经验的亚组分析。

Cerebrovasc Dis. 2010;30(5):514-8. doi: 10.1159/000319776. Epub 2010 Sep 22.

[Thrombolysis in stroke--results of the ECASS study (European Cooperative Acute Stroke Study)].[卒中溶栓治疗——欧洲急性卒中协作研究（ECASS）的结果]

Nervenarzt. 1995 Aug;66(8 Suppl):1-8.

IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.

Neurology. 2006 Nov 14;67(9):1724-5; author reply 1724-5. doi: 10.1212/01.wnl.0000247900.23792.8b.

Intravenous thrombolysis is feasible and safe in multiethnic Asian stroke patients in Singapore.静脉溶栓在新加坡多民族亚洲中风患者中是可行且安全的。

Int J Stroke. 2009 Oct;4(5):320-1. doi: 10.1111/j.1747-4949.2009.00325.x.

引用本文的文献

Comparison of Effectiveness and Safety of Low-Dose Versus Standard-Dose Intravenous Recombinant Tissue Plasminogen Activator in Patients With Acute Ischemic Stroke: A Meta-Analysis.低剂量与标准剂量静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中患者的有效性和安全性比较：一项荟萃分析

Cureus. 2023 Feb 28;15(2):e35571. doi: 10.7759/cureus.35571. eCollection 2023 Feb.

A systematic review of the cost-effectiveness of emergency interventions for stroke in low- and middle-income countries.低收入和中等收入国家中风紧急干预措施成本效益的系统评价。

Afr J Emerg Med. 2020;10(Suppl 1):S90-S94. doi: 10.1016/j.afjem.2020.05.009. Epub 2020 Jun 11.

Acute management of stroke in Iran: Obstacles and solutions.伊朗中风的急性管理：障碍与解决方案。

Iran J Neurol. 2017 Apr 4;16(2):62-71.

Assessment of neurologists' knowledge regarding intravenous fibrinolytic therapy for acute stroke in Shanxi province in China.中国山西省神经科医生关于急性卒中静脉溶栓治疗知识的评估。

BMC Health Serv Res. 2017 May 18;17(1):358. doi: 10.1186/s12913-017-2300-6.

Stroke in patients with diabetes mellitus: a study from North Western Nigeria.糖尿病患者的中风：来自尼日利亚西北部的一项研究。

Afr Health Sci. 2016 Sep;16(3):781-789. doi: 10.4314/ahs.v16i3.19.

Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study.静脉注射重组组织型纤溶酶原激活剂治疗急性缺血性卒中：一项可行性和安全性研究。

Int J Gen Med. 2016 Oct 25;9:361-367. doi: 10.2147/IJGM.S112430. eCollection 2016.

Low-Dose Versus Standard-Dose Tissue Plasminogen Activator in Acute Ischemic Stroke in Asian Populations: A Meta-Analysis.亚洲人群急性缺血性卒中中低剂量与标准剂量组织型纤溶酶原激活剂的比较：一项荟萃分析

Medicine (Baltimore). 2015 Dec;94(52):e2412. doi: 10.1097/MD.0000000000002412.

Eligibility assessment for intravenous thrombolytic therapy in acute ischemic stroke patients; evaluating barriers for implementation.急性缺血性脑卒中患者静脉溶栓治疗的资格评估；评估实施障碍。

Iran Red Crescent Med J. 2014 May;16(5):e11284. doi: 10.5812/ircmj.11284. Epub 2014 May 5.

Design of a standard Iranian protocol of Intravenous thrombolysis with tissue plasminogen activator: A national project.伊朗组织型纤溶酶原激活剂静脉溶栓标准方案的设计：一个国家项目。

Iran J Neurol. 2013;12(2):72-4.

Factors associated with death and predictors of one-month mortality from stroke in Kano, Northwestern Nigeria.尼日利亚西北部卡诺州与中风死亡相关的因素及中风1个月死亡率的预测因素。

J Neurosci Rural Pract. 2013 Aug;4(Suppl 1):S56-61. doi: 10.4103/0976-3147.116460.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验